Reviva Pharmaceuticals Holdings (RVPH)
NASDAQ:RVPH
US Market
Holding RVPH?
Track your performance easily

Reviva Pharmaceuticals Holdings (RVPH) Financial Statements

200 Followers

Reviva Pharmaceuticals Holdings Financial Overview

Reviva Pharmaceuticals Holdings's market cap is currently ―. The company's EPS TTM is $-1.295; its P/E ratio is -0.93; Reviva Pharmaceuticals Holdings is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.85M$ 8.42M$ -10.25M$ -10.47M$ -12.42M
EBITDA$ -7.85M$ 8.42M$ -10.25M$ -10.47M$ -12.42M
Net Income Common Stockholders$ -7.86M$ -7.43M$ -9.72M$ -10.49M$ -12.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.18M$ 11.97M$ 23.37M$ 4.97M$ 11.15M
Total Assets$ 8.05M$ 13.50M$ 23.70M$ 5.39M$ 11.84M
Total Debt$ 207.50K$ 332.00K$ 0.00$ 222.50K$ 222.50K
Net Debt$ -5.97M$ -11.64M$ -23.37M$ -4.75M$ -10.93M
Total Liabilities$ 14.09M$ 14.84M$ 17.98M$ 13.91M$ 10.22M
Stockholders Equity$ -6.04M$ -1.35M$ 5.72M$ -8.52M$ 1.62M
Cash Flow-
Free Cash Flow$ -8.48M$ -11.73M$ -8.88M$ -6.18M$ -5.32M
Operating Cash Flow$ -8.48M$ -11.73M$ -8.88M$ -6.18M$ -5.32M
Investing Cash Flow-----
Financing Cash Flow$ 2.68M$ 332.00K$ 27.27M-$ 5.21M
Currency in USD

Reviva Pharmaceuticals Holdings Earnings and Revenue History

Reviva Pharmaceuticals Holdings Debt to Assets

Reviva Pharmaceuticals Holdings Cash Flow

Reviva Pharmaceuticals Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis